2026-04-13T15:17:31Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1555172025-12-05T14:53:03Zcom_2072_1057col_2072_478917col_2072_478924
RECERCAT
author
Ramírez-Garza, Sonia L.
author
Laveriano-Santos, Emily P.
author
Marhuenda-Muñoz, María
author
Storniolo, Carolina Emilia
author
Resserra i Rimbau, Anna
author
Vallverdú i Queralt, Anna
author
Lamuela Raventós, Rosa Ma.
2020-04-16T10:18:45Z2020-04-16T10:18:45Z2018-12-032020-04-16T10:18:45Z
The effect of resveratrol (RV) intake has been reviewed in several studies performed in humans with different health status. The purpose of this review is to summarize the results of clinical trials of the last decade, in which RV was determined in biological samples such as human plasma, urine, and feces. The topics covered include RV bioavailability, pharmacokinetics, effects on cardiovascular diseases, cognitive diseases, cancer, type 2 diabetes (T2D), oxidative stress, and inflammation states. The overview of the recent research reveals a clear tendency to identify RV in plasma, showing that its supplementation is safe. Furthermore, RV bioavailability depends on several factors such as dose, associated food matrix, or time of ingestion. Notably, enterohepatic recirculation of RV has been observed, and RV is largely excreted in the urine within the first four hours after consumption. Much of the research on RV in the last 10 years has focused on its effects on pathologies related to oxidative stress, inflammatory biomarkers, T2D, cardiovascular diseases, and neurological diseases
cc-by (c) Ramírez-Garza, Sonia L. et al., 2018 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess
Biodisponibilitat
Obesitat
Trastorns del metabolisme
Antioxidants
Farmacologia
Bioavailability
Obesity
Disorders of metabolism
Antioxidants
Pharmacology
Health Effects of Resveratrol: Results from Human Intervention Trials
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion